Effective Management of a Rare Case of Pediatric ANCA-Associated Vasculitis With Rituximab and Mycophenolate Mofetil

Yi Fang; Ali Kurady; Faris Q. Hashim; Blaine Berger; Arundhati Rao

doi:10.12659/AJCR.949274

04 January 2026 : Case report USA

Effective Management of a Rare Case of Pediatric ANCA-Associated Vasculitis With Rituximab and Mycophenolate Mofetil

Challenging differential diagnosis, Diagnostic / therapeutic accidents, Management of emergency care, Rare disease

Yi Fang^{ABCDEF 1}, Ali Kurady^{A 2}, Faris Q. Hashim^{ABCDEFG 2*}, Blaine Berger^{B 3}, Arundhati Rao^{B 3}

DOI: 10.12659/AJCR.949274

Am J Case Rep 2026; 27:e949274

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 Low-power (200×) hematoxylin and eosin–stained section showing 2 glomeruli, each exhibiting prominent crescent formation. The crescents are cellular, composed of proliferating parietal epithelial cells and infiltrating leukocytes, partially to completely encircling the glomerular tufts. There is associated segmental fibrinoid necrosis and tuft collapse. The surrounding interstitium shows mild inflammatory infiltrates.

Back to the Article

Effective Management of a Rare Case of Pediatric ANCA-Associated Vasculitis With Rituximab and Mycophenolate Mofetil

Your Privacy